BackBiocon Limited Overview

Biocon Limited Current Assets

Biocon Limited's current assets is $180B.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$176.86B
↓ 6.76% YoYΔ $-12.83B vs prior year quarter

Peer trimmed avg / median

Loading

Biocon Limited Current Assets History

Loading

Biocon Limited vs. peers: Current Assets Comparison

Loading

Biocon Limited Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Biocon Limited (BIOCON.NS) FAQ

As of the most recent data (June 2026), BIOCON.NS shows a current assets of $180B. That compares with $190B in the prior-year period — down 6.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BIOCON.NS's current assets is now $180B (was $190B) — a 6.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Biocon Limited is outperforming or lagging.

Tracking BIOCON.NS's current assets over time shows whether Biocon Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $180B That compares with $190B in the prior-year period — down 6.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Biocon Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $180B) with ownership activity and broader fundamentals.

Biocon Limited's current assets is $180B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.